Anixa Biosciences (ANIX) News Today $3.66 -0.02 (-0.41%) As of 10:04 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ANIX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Breast cancer vaccine showing progressJune 17 at 1:31 PM | msn.comAnixa Biosciences (NASDAQ:ANIX) Receives Buy Rating from D. Boral CapitalD. Boral Capital reiterated a "buy" rating and issued a $10.00 price target on shares of Anixa Biosciences in a research note on Tuesday.June 10, 2025 | marketbeat.comAnixa Biosciences' Breast Cancer Vaccine Receives National News CoverageJune 10, 2025 | prnewswire.comBreakthrough vaccine could eradicate breast cancer, shows 75% immune response in trialJune 9, 2025 | msn.comAnixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the ESMO Gynaecological Cancers Congress 2025June 9, 2025 | prnewswire.comAnixa Biosciences (NASDAQ:ANIX) Upgraded by Wall Street Zen to "Hold" RatingJune 8, 2025 | americanbankingnews.comAnixa Biosciences (NASDAQ:ANIX) Rating Increased to Hold at Wall Street ZenWall Street Zen raised shares of Anixa Biosciences from a "sell" rating to a "hold" rating in a research report on Friday.June 7, 2025 | marketbeat.comAnixa Biosciences, Inc. (NASDAQ:ANIX) CEO Amit Kumar Acquires 10,000 SharesJune 6, 2025 | insidertrades.comH.C. Wainwright maintains Buy rating on Anixa Biosciences stockJune 6, 2025 | uk.investing.comAnixa Biosciences, Inc. (NASDAQ:ANIX) CEO Buys $28,500.00 in StockAnixa Biosciences, Inc. (NASDAQ:ANIX - Get Free Report) CEO Amit Kumar acquired 10,000 shares of the firm's stock in a transaction that occurred on Wednesday, June 4th. The shares were purchased at an average price of $2.85 per share, with a total value of $28,500.00. Following the acquisition, the chief executive officer now owns 569,925 shares of the company's stock, valued at approximately $1,624,286.25. This trade represents a 1.79% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.June 5, 2025 | marketbeat.comHC Wainwright Lifts Earnings Estimates for Anixa BiosciencesAnixa Biosciences, Inc. (NASDAQ:ANIX - Free Report) - Equities research analysts at HC Wainwright raised their FY2025 earnings per share (EPS) estimates for Anixa Biosciences in a report issued on Tuesday, June 3rd. HC Wainwright analyst Y. Chen now forecasts that the company will earn ($0.38) peJune 5, 2025 | marketbeat.comAnixa Biosciences' Breast Cancer Vaccine Featured in NewsNation InterviewJune 3, 2025 | prnewswire.comAnixa Biosciences (NASDAQ:ANIX) Announces Quarterly Earnings ResultsAnixa Biosciences (NASDAQ:ANIX - Get Free Report) posted its quarterly earnings results on Tuesday. The company reported ($0.09) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.10) by $0.01.June 3, 2025 | marketbeat.comAnixa Biosciences Announces Completion of Enrollment in Phase 1 Trial of Breast Cancer VaccineJune 2, 2025 | prnewswire.comBreast cancer vaccine enters second trial phase | Elizabeth Vargas ReportsMay 31, 2025 | msn.comBreast cancer vaccine moving to critical phaseMay 31, 2025 | msn.comD. Boral Capital Reaffirms "Buy" Rating for Anixa Biosciences (NASDAQ:ANIX)D. Boral Capital reaffirmed a "buy" rating and issued a $10.00 target price on shares of Anixa Biosciences in a research report on Thursday.May 30, 2025 | marketbeat.comAnixa Biosciences (ANIX) Expected to Announce Earnings on TuesdayAnixa Biosciences (NASDAQ:ANIX) will be releasing its Q2 2025 earnings before the market opens on Tuesday, June 3. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-6-3-anixa-biosciences-inc-stock/)May 28, 2025 | marketbeat.comAnixa Biosciences CEO Provides Letter to Shareholders Outlining Significant Progress and Advancement Towards Potentially Transformative MilestonesMay 19, 2025 | prnewswire.comAnixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the American Society of Clinical Oncology (ASCO) Annual MeetingMay 12, 2025 | prnewswire.comAnixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20thApril 30, 2025 | prnewswire.comAnixa Biosciences receives notice of allowance for new patent from USPTOApril 15, 2025 | markets.businessinsider.comAnixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property PortfolioApril 14, 2025 | prnewswire.comAnixa Biosciences (NASDAQ:ANIX) Earns Buy Rating from D. Boral CapitalD. Boral Capital reissued a "buy" rating and set a $10.00 price objective on shares of Anixa Biosciences in a research report on Thursday.April 12, 2025 | marketbeat.comAnixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine TechnologyApril 9, 2025 | prnewswire.comAnixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine TechnologyApril 9, 2025 | prnewswire.comAnixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9thApril 1, 2025 | prnewswire.comEquities Analysts Set Expectations for ANIX Q1 EarningsAnixa Biosciences, Inc. (NASDAQ:ANIX - Free Report) - Equities researchers at HC Wainwright issued their Q1 2026 earnings estimates for shares of Anixa Biosciences in a research note issued to investors on Tuesday, March 25th. HC Wainwright analyst Y. Chen anticipates that the company will post eMarch 27, 2025 | marketbeat.comAnixa Biosciences to develop AI-guided cancer vaccines with Verdi SolutionsMarch 26, 2025 | markets.businessinsider.comAnixa Biosciences (NASDAQ:ANIX) Given "Buy" Rating at HC WainwrightHC Wainwright restated a "buy" rating and set a $7.00 price target on shares of Anixa Biosciences in a report on Tuesday.March 26, 2025 | marketbeat.com1ANIX : EXCLUSIVE: Anixa Biosciences Inks Letter of Intent with Austria-Based VERDI...March 25, 2025 | benzinga.comAnixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer VaccinesMarch 25, 2025 | prnewswire.comAnixa receives notice of allowance from USPTO for ovarian cancer vaccineMarch 25, 2025 | markets.businessinsider.comAnixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer VaccineMarch 24, 2025 | prnewswire.comAnixa Biosciences initiated with a Buy at MaximMarch 22, 2025 | markets.businessinsider.comMaxim Group Initiates Coverage of Anixa Biosciences (ANIX) with Buy RecommendationMarch 22, 2025 | msn.comMaxim Group Initiates Coverage on Anixa Biosciences (NASDAQ:ANIX)Maxim Group started coverage on shares of Anixa Biosciences in a research report on Friday. They set a "buy" rating and a $10.00 target price on the stock.March 22, 2025 | marketbeat.comAnixa Biosciences CEO to Present at the 2025 CAGLA NeauxCancer Conference on March 28thMarch 17, 2025 | prnewswire.comAnixa Biosciences (NASDAQ:ANIX) Posts Earnings ResultsAnixa Biosciences (NASDAQ:ANIX - Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($0.10) earnings per share for the quarter, hitting the consensus estimate of ($0.10).March 12, 2025 | marketbeat.comAnixa Biosciences 2025 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested PartiesMarch 10, 2025 | prnewswire.comAnixa Biosciences (ANIX) to Release Earnings on TuesdayAnixa Biosciences (NASDAQ:ANIX) will be releasing earnings before the market opens on Tuesday, March 11, Financial Modeling Prep reports.March 10, 2025 | marketbeat.comAnixa Biosciences Announces Chief Development Officer Dr. Pam Garzone to Speak at the Alliance for Cancer Gene Therapy Summit 2025 on March 19thMarch 3, 2025 | prnewswire.comSpotlight On February 2025's Promising Penny StocksFebruary 27, 2025 | finance.yahoo.comAnixa Biosciences, Inc.: Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical TrialFebruary 27, 2025 | finanznachrichten.deAnixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical TrialFebruary 26, 2025 | prnewswire.comAnixa Biosciences' Breast Cancer Vaccine was Featured on Fox News' "America Reports"February 25, 2025 | prnewswire.comAnixa Biosciences Featured in Breaking Cancer News Article on Novel CAR-T Therapy for Ovarian CancerFebruary 24, 2025 | prnewswire.comHC Wainwright Issues Positive Estimate for ANIX EarningsAnixa Biosciences, Inc. (NASDAQ:ANIX - Free Report) - Investment analysts at HC Wainwright increased their Q1 2025 EPS estimates for shares of Anixa Biosciences in a research note issued on Tuesday, February 18th. HC Wainwright analyst Y. Chen now expects that the company will post earnings of ($February 22, 2025 | marketbeat.comAnixa Biosciences (NASDAQ:ANIX) Given Buy Rating at HC WainwrightHC Wainwright reissued a "buy" rating and set a $7.00 price target on shares of Anixa Biosciences in a research note on Tuesday.February 19, 2025 | marketbeat.comAnixa Biosciences, Inc.: Anixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical TrialFebruary 19, 2025 | finanznachrichten.de Get Anixa Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIX and its competitors with MarketBeat's FREE daily newsletter. Email Address ANIX Media Mentions By Week ANIX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANIX News Sentiment▼-1.320.56▲Average Medical News Sentiment ANIX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANIX Articles This Week▼12▲ANIX Articles Average Week Get Anixa Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Septerna News PureTech Health News Oruka Therapeutics News SIGA Technologies News REGENXBIO News Precigen News Atai Life Sciences News Mereo BioPharma Group News COMPASS Pathways News ABIVAX Société Anonyme News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANIX) was last updated on 6/18/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredThe Shocking Link Between A.I. and Your MoneyThe AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored72 Hours Until Musk’s $34 Trillion AI Network BeginsIn just 72 hours, Elon Musk is expected to flip the switch on Tesla’s autonomous network in Austin, Texas. ...The Oxford Club | SponsoredSorry about the swear wordWhat a huge few months for Bitcoin. First, Bitcoin hit $100,000… Then, Donald Trump pledged to create an...Manward Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anixa Biosciences Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Anixa Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ANIX Stock Free ANIX Stock Alerts